Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Biochim Biophys Acta ; 1862(3): 310-22, 2016 03.
Artículo en Inglés | MEDLINE | ID: mdl-26432480

RESUMEN

The central nervous system (CNS) is a very unique system with multiple features that differentiate it from systemic tissues. One of the most captivating aspects of its distinctive nature is the presence of the blood brain barrier (BBB), which seals it from the periphery. Therefore, to preserve tissue homeostasis, the CNS has to rely heavily on resident cells such as microglia. These pivotal cells of the mononuclear lineage have important and dichotomous roles according to various neurological disorders. However, certain insults can overwhelm microglia as well as compromising the integrity of the BBB, thus allowing the infiltration of bone marrow-derived macrophages (BMDMs). The use of myeloablation and bone marrow transplantation allowed the generation of chimeric mice to study resident microglia and infiltrated BMDM separately. This breakthrough completely revolutionized the way we captured these 2 types of mononuclear phagocytic cells. We now realize that microglia and BMDM exhibit distinct features and appear to perform different tasks. Since these cells are central in several pathologies, it is crucial to use chimeric mice to analyze their functions and mechanisms to possibly harness them for therapeutic purpose. This review will shed light on the advent of this methodology and how it allowed deciphering the ontology of microglia and its maintenance during adulthood. We will also compare the different strategies used to perform myeloablation. Finally, we will discuss the landmark studies that used chimeric mice to characterize the roles of microglia and BMDM in several neurological disorders. This article is part of a Special Issue entitled: Neuro Inflammation edited by Helga E. de Vries and Markus Schwaninger.


Asunto(s)
Trasplante de Médula Ósea , Sistema Nervioso Central/patología , Macrófagos/patología , Enfermedades del Sistema Nervioso/patología , Animales , Trasplante de Médula Ósea/métodos , Encéfalo/metabolismo , Encéfalo/patología , Sistema Nervioso Central/metabolismo , Modelos Animales de Enfermedad , Humanos , Macrófagos/metabolismo , Ratones , Ratones Transgénicos , Microglía/metabolismo , Microglía/patología , Enfermedades del Sistema Nervioso/genética
2.
Brain Behav Immun ; 46: 221-31, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25733102

RESUMEN

Excitotoxic cell death is a crucial mechanism through which neurodegeneration occurs in numerous pathologies of the central nervous system (CNS), such as Alzheimer's disease, stroke and spinal cord injury. Toll-like receptors (TLRs) are strongly expressed on microglial cells and are key regulators of the innate immune response to neuronal damage. However, it is still unclear whether their stimulation is protective or harmful in excitotoxic contexts. In this study, we demonstrate that systemic administration of lipopolysaccharide (LPS) or Pam3CSK4 24h prior to an intrastriatal injection of kainic acid (KA) significantly protected cortical neurons in the acute phase of injury. Protection could not be detected with the TLR3 ligand poly-IC. Histological analyses revealed that microglia of LPS and Pam3CSK4 pre-conditioned group were primed to react to injury and exhibited a stronger expression of Tnf and Tlr2 mRNA. We also found that mice deficient for MyD88, a critical adaptor protein for most TLR, were more vulnerable than WT mice to KA-induced excitotoxicity at early (12h and 24h) and late (10days) time points. Finally, bone-marrow chimeric mice revealed that MyD88 signaling in CNS resident cells, but not in cells of hematopoietic origin, mediates the protective effect. This study unravels the potential of TLR2 and TLR4 agonists to induce a protective state of preconditioning against KA-mediated excitotoxicity and further highlights the beneficial role of cerebral MyD88 signaling in this context.


Asunto(s)
Muerte Celular/fisiología , Ácido Kaínico/toxicidad , Factor 88 de Diferenciación Mieloide/metabolismo , Neuronas/metabolismo , Neuroprotección/fisiología , Receptores Toll-Like/metabolismo , Animales , Muerte Celular/efectos de los fármacos , Lipopéptidos/farmacología , Lipopolisacáridos , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Factor 88 de Diferenciación Mieloide/genética , Neuronas/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Transducción de Señal/fisiología , Receptores Toll-Like/genética
3.
J Exp Med ; 212(4): 481-95, 2015 Apr 06.
Artículo en Inglés | MEDLINE | ID: mdl-25779633

RESUMEN

An imbalance between remyelinating and demyelinating rates underlies degenerative processes in demyelinating diseases such as multiple sclerosis. An optimal therapeutic strategy would be to stimulate remyelination while limiting demyelination. Although accumulation of myelin debris impairs remyelination, the mechanisms regulating the clearance of such debris by mononuclear phagocytic cells are poorly understood. We demonstrate that after cuprizone intoxication, CCR2-dependent infiltration of mouse bone marrow-derived cells is abundant in demyelinating areas, but that these cells do not impact demyelination. However, in CX3CR1-deficient mice, the clearance of myelin debris by microglia was blocked greatly, affecting the integrity of the axon and myelin sheaths and thus preventing proper remyelination. These results highlight the crucial role played by CX3CR1 in myelin removal and show that there can be no efficient remyelination after a primary demyelinating insult if myelin clearance by microglia is impaired.


Asunto(s)
Axones/inmunología , Células de la Médula Ósea/inmunología , Enfermedades Desmielinizantes/inmunología , Microglía/inmunología , Vaina de Mielina/inmunología , Fagocitos/inmunología , Animales , Axones/patología , Células de la Médula Ósea/patología , Receptor 1 de Quimiocinas CX3C , Enfermedades Desmielinizantes/genética , Enfermedades Desmielinizantes/patología , Ratones , Ratones Noqueados , Microglía/patología , Vaina de Mielina/patología , Fagocitos/patología , Receptores CCR2/genética , Receptores CCR2/inmunología , Receptores de Quimiocina/genética , Receptores de Quimiocina/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA